LRRK2 and melanoma: Immunofluorescence using a variety of commercially available antibodies against LRRK2 (MJFF C41-2, UDD3, and N231) and GFP (13970; Abcam) was performed on the GFP-LRRK2 A549 line as well as WT versus CRISPR LRRK2 KO A549 cells (gift of Dario Alessi), WT versus TALEN LRRK2 KO murine RAW 264.7 macrophages (from the Michael J. Fox Foundation), and WT compared with siRNA LRRK2 knockdown human melanoma Malme-3M cells.